덱스트로프로폭시펜

덱스트로프로폭시펜
덱스트로프로폭시펜 구조식 이미지
카스 번호:
469-62-5
한글명:
덱스트로프로폭시펜
동의어(한글):
덱스트로프로폭시펜;프로폭시펜
상품명:
PROPOXYPHENE
동의어(영문):
SK 65;Dolene;Algafan;Femadol;Antalvic;Depromic;Proxagesic;PROPOXYPHENE;D-PROPOXYPHENE;(+)-propoxyphen
CBNumber:
CB4716127
분자식:
C22H29NO2
포뮬러 무게:
339.48
MOL 파일:
469-62-5.mol

덱스트로프로폭시펜 속성

녹는점
75-76°
알파
D25 +67.3° (c = 0.6 in chloroform)
끓는 점
475.43°C (rough estimate)
밀도
1.0751 (rough estimate)
굴절률
1.5614 (estimate)
인화점
2℃
저장 조건
2-8°C
산도 계수 (pKa)
pKa 6.3(50% aq EtOH) (Uncertain)
EPA
Propoxyphene (469-62-5)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 F,Xn,T
위험 카페고리 넘버 11-20/21/22-36-52/53-25
안전지침서 16-26-36/37-61-45-36/37/39
유엔번호(UN No.) 3249
WGK 독일 2
위험 등급 6.1(b)
포장분류 III
유해 물질 데이터 469-62-5(Hazardous Substances Data)
독성 An opioid analgesic similar in structure to methadone. It is a much less potent analgesic than morphine and is devoid of antipyretic or anti-inflammatory effects. Its side effects are qualitatively similar to codeine. The clinical indications for propoxyphene are much the same as for aspirin. It is used when the degree of analgesia required is less than that produced by morphine. Recent clinical trials suggest that propoxyphene is no more effective in controlling mild pain than is aspirin. Because they act by different mechanisms, aspirin and propoxyphene have often been given in combination. Recently, there has been a trend away from use of propoxyphene because its weak analgesic properties do not compensate for other problems with its use. Interestingly, the analgesic activity of propoxyphene resides largely in the dextrorotatory isomer, whereas the antitussive effect is produced primarily by the levorotatory isomer. The use of propoxyphene was banned in the United States in November 2010. The oral LD50 in rats is 84 mg/kg.
그림문자(GHS): GHS hazard pictogramsGHS hazard pictograms
신호 어: Danger
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H225 고인화성 액체 및 증기 인화성 액체 구분 2 위험 GHS hazard pictograms P210,P233, P240, P241, P242, P243,P280, P303+ P361+P353, P370+P378,P403+P235, P501
H319 눈에 심한 자극을 일으킴 심한 눈 손상 또는 자극성 물질 구분 2A 경고 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
예방조치문구:
P210 열·스파크·화염·고열로부터 멀리하시오 - 금연 하시오.
P261 분진·흄·가스·미스트·증기·...·스프레이의 흡입을 피하시오.
P337+P313 눈에 대한 자극이 지속되면 의학적인 조치· 조언를 구하시오.
P403+P235 환기가 잘 되는 곳에 보관하고 저온으로 유지하시오.

덱스트로프로폭시펜 C화학적 특성, 용도, 생산

용도

Analgesic.

정의

ChEBI: The (1S,2R)-(+)-diastereoisomer of propoxyphene.

Biological Functions

Propoxyphene (dextropropoxyphene; Darvon) is structurally related to methadone but is much less potent as an analgesic. Compared with codeine, propoxyphene is approximately half as potent and is indicated for the treatment of mild pain. It is not antipyretic or antiinflammatory like aspirin and is less useful than aspirin in most cases of mild pain. Toxicity from propoxyphene, especially in combination with other sedatives, such as alcohol, has led to a decrease in its use. Death following ingestion of alcohol in combination with propoxyphene can occur rapidly (within 20 minutes to 1 hour). The drug is not indicated for those with histories of suicide or depressive illnesses.
Like meperidine, propoxyphene has an active metabolite, norpropoxyphene, that is not analgesic but has excitatory and local anesthetic effects on the heart similar to those of quinidine. Use of the drug during pregnancy is not safe.Teratogenic effects have been observed in newborns, as have withdrawal signs at birth. As with morphine, propoxyphene requires adequate hepatic and renal clearance to prevent toxicity and drug accumulation. It is thus contraindicated in the elderly patient and those with renal or liver disease.
Propoxyphene interacts with several drugs. The use of sedatives in combination with propoxyphene can be fatal. In addition, the metabolism of the drug is increased in smokers due to induction of liver enzymes. Thus, smokers may require a higher dose of the drug for pain relief. Propoxyphene enhances the effects of both warfarin and carbamazepine and may increase the toxicity associated with both drugs, such as bleeding and sedation, respectively.
The abuse liability of propoxyphene is low because of the extreme irritation it causes at the site of injection. Oral use is the preferred route of administration for this reason.

일반 설명

Most of the structural changes to the methadone skeletonresulted in compounds with decreased opioid potencies, thusmost of these compounds, with the exception of LAAM werenot developed. Propoxyphene is a derivative of methadonemarketed in 1957 as the enantiomerically pure (2S, 3R)-4-(Dimethylamino)-3-methyl-1,2,-diphenyl-2-butanol propionate(ester). It is only about 1/10th as potent as morphine asan analgesic yet retains all the same opioid adverse effects.One propoxyphene 65-mg capsule has the same analgesic effectof 650 mg of aspirin or 1,000 mg of acetaminophen, thusoverdoses of propoxyphene can occur if patients do not followthe prescribed dose. Between 1981 and 1999, 2,110 accidentaldeaths were reported because of propoxyphene.Propoxyphene and all propoxyphene combination productsare listed using the Beers criteria as medications to avoid inpatients older than 65 years of age. The metabolism ofpropoxyphene also contributes to the potential dangers of thedrug. Propoxyphene is metabolized via N-demethylation toform norpropoxyphene. Norpropoxyphene has been shownto build up in cardiac tissues and result in naloxone-insensitivecardiotoxicity. The weak analgesic action and potentialrisk to the patient have some health practitioners advocatingto remove all drugs containing propoxyphene from the market.The hydrochloride salt is marketed as Darvon, the napsylatesalt as Darvon-N, both salts are also available combinedwith acetaminophen (Darvocet, Darvocet-N) and apropoxyphene, aspirin, caffeine product is also available.

Safety Profile

Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Human systemic effects by ingestion: change in cardiac rate, respiratory depression, and coma. When heated to decomposition it emits toxic fumes of NOx.

덱스트로프로폭시펜 준비 용품 및 원자재

원자재

준비 용품


덱스트로프로폭시펜 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved